ReviewJournal of personalized medicine2024
Opportunities and Challenges of Chatbots in Ophthalmology: A Narrative Review.
Review in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Comparison of AI-based Chatbot Performance in Analyzing Clinical Scenarios versus Medical Residents: A Novel Approach in Chest Diseases Education.Thoracic research and practice · 2026Article
- Psychological Risk Assessment in Plastic Surgery via a DeepSeek Large Language Model: A Retrospective Cohort Study.Aesthetic plastic surgery · 2026Article
- Comparative performance of chatgpt and gemini in diagnostic classification and clinical reasoning for open-angle glaucoma: a standardized scenario-based study.International ophthalmology · 2026Article
- Article
- The development and use of chatbots in enhancing health care access for underserved and vulnerable populations: a scoping review.BMC public health · 2025Article
- Global perspectives of ophthalmologists on artificial intelligence adoption in clinical practice.International journal of retina and vitreous · 2025Article
- Ultrasound-based deep learning model as an assistant improves the diagnosis of ovarian tumors: a multicenter study.Insights into imaging · 2025Article
- Comparative Assessment of Large Language Models in Optics and Refractive Surgery: Performance on Multiple-Choice Questions.Vision (Basel, Switzerland) · 2025Article
- Performance of ChatGPT-4 Omni and Gemini 1.5 Pro on Ophthalmology-Related Questions in the Turkish Medical Specialty Exam.Turkish journal of ophthalmology · 2025Article
- Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study.BMC public health · 2025Article
- Article
- The application of artificial intelligence-generated content in ophthalmology education.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is becoming increasingly influential in ophthalmology, particularly through advancements in machine learning, deep learning, robotics, neural networks, and natural language processing (NLP). Among these, NLP-based chatbots are the most readily accessible and are driven by AI-based large language models (LLMs). These chatbots have facilitated new research avenues and have gained traction in both clinical and surgical applications in ophthalmology. They are also increasingly being utilized in studies on ophthalmology-related exams, particularly those containing multiple-choice questions (MCQs). This narrative review evaluates both the opportunities and the challenges of integrating chatbots into ophthalmology research, with separate assessments of studies involving open- and close-ended questions. While chatbots have demonstrated sufficient accuracy in handling MCQ-based studies, supporting their use in education, additional exam security measures are necessary. The research on open-ended question responses suggests that AI-based LLM chatbots could be applied across nearly all areas of ophthalmology. They have shown promise for addressing patient inquiries, offering medical advice, patient education, supporting triage, facilitating diagnosis and differential diagnosis, and aiding in surgical planning. However, the ethical implications, confidentiality concerns, physician liability, and issues surrounding patient privacy remain pressing challenges. Although AI has demonstrated significant promise in clinical patient care, it is currently most effective as a supportive tool rather than as a replacement for human physicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.